F
Federico Campigotto
Researcher at Harvard University
Publications - 33
Citations - 2159
Federico Campigotto is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer & Cumulative incidence. The author has an hindex of 18, co-authored 30 publications receiving 1836 citations. Previous affiliations of Federico Campigotto include Dana Corporation.
Papers
More filters
Journal ArticleDOI
BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
Aldo M. Roccaro,Antonio Sacco,Patricia Maiso,Abdel Kareem Azab,Yu-Tzu Tai,Michaela R. Reagan,Feda Azab,Ludmila Flores,Federico Campigotto,Edie Weller,Kenneth C. Anderson,David T. Scadden,Irene M. Ghobrial +12 more
TL;DR: In vitro and in vivo studies demonstrated that exosome transfer from BM-MSCs to clonal plasma cells represents a previously undescribed and unique mechanism that highlights the contribution of BM- MSCs to MM disease progression.
Journal ArticleDOI
Prognostic role of circulating exosomal miRNAs in multiple myeloma
Salomon Manier,Salomon Manier,Chia Jen Liu,Chia Jen Liu,Chia Jen Liu,Hervé Avet-Loiseau,Jihye Park,Jiantao Shi,Federico Campigotto,Karma Salem,Daisy Huynh,Siobhan Glavey,Bradley Rivotto,Antonio Sacco,Antonio Sacco,Aldo M. Roccaro,Aldo M. Roccaro,Juliette Bouyssou,Stephane Minvielle,Philippe Moreau,Thierry Facon,Xavier Leleu,Edie Weller,Lorenzo Trippa,Irene M. Ghobrial +24 more
TL;DR: The findings support the use of circulating exosomal miRNAs to improve the identification of patients with newly diagnosed MM with poor outcomes, and require further validation in other independent prospective MM cohorts.
Journal ArticleDOI
Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients
Jacalyn Rosenblatt,Irit Avivi,Baldev Vasir,Lynne Uhl,Nikhil C. Munshi,Tami Katz,Bimalangshu R. Dey,Poorvi Somaiya,Heidi Mills,Federico Campigotto,Edie Weller,Robin Joyce,James D. Levine,Dimitrios Tzachanis,Paul G. Richardson,Jacob P. Laubach,Noopur Raje,Vassiliki A. Boussiotis,Yan Emily Yuan,Lina Bisharat,Viki Held,Jacob M. Rowe,Kenneth C. Anderson,Donald Kufe,David Avigan +24 more
TL;DR: The posttransplant period for patients with multiple myeloma provides a unique platform for cellular immunotherapy in which vaccination with dendritic cell/myeloma fusion fusions resulted in the marked expansion of myelomas-specific T cells and cytoreduction of minimal residual disease.
Journal ArticleDOI
Marked hyperferritinemia does not predict for HLH in the adult population
Alison M. Schram,Federico Campigotto,Ann Mullally,Annemarie E. Fogerty,Elena Massarotti,Donna Neuberg,Nancy Berliner +6 more
TL;DR: A retrospective analysis of conditions associated with profoundly elevated ferritin in the adult population suggests that marked hyperferritinemia can be seen in a variety of conditions and is not specific for HLH in adults.
Journal ArticleDOI
Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study
Jessica Donato,Federico Campigotto,Erik J. Uhlmann,Erika Coletti,Donna Neuberg,Griffin M. Weber,Jeffrey I. Zwicker +6 more
TL;DR: It is concluded that intracranial hemorrhage is frequently observed in patients with brain metastases, but that therapeutic anticoagulation does not increase the risk for intrac Cranial hemorrhages.